Immune remodeling of liver metastases: From molecular mechanisms to therapeutic strategies
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-09 · 1881 (4) · 189618
DOI: 10.1016/j.bbcan.2026.189618 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-09. Verfasst von Wenchao Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 1…. Hauptthemen laut MEDLINE: Liver Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 135 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Chinese Academy of Medical Sciences Initiative for Innovative Medicine, Peking Union Medical College.
Abstract (Originalsprache)
Liver metastasis is an intractable clinical challenge due to profound immunosuppression within the liver metastatic niche (LMN), which fundamentally limits immunotherapy efficacy. The unique immune landscape of LMN is shaped by inter-organ, primary tumor-origin, and intra-lesional heterogeneity, driven by multilayered mechanisms including poor immunogenicity, antigen presentation deficiency, antitumor immune cell dysfunction, hyperactive immunosuppressive cells, spatial immune remodeling and host systemic factors. Temporally, LMN evolves from immune surveillance to immune escape. Notably, distinct primary tumors share certain common LMN features, enabling a potential paradigm shift from primary tumor-based classification to LMN-guided subtyping. Precision strategies integrating multi-omics, dynamic biomarkers, and combinatorial interventions hold promise to overcome LMN-driven resistance. This review delineates the spatiotemporal immune remodeling of the LMN, summarizes current therapeutic strategies, and highlights future translational priorities for precision immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; Key Laboratory of Research in Pancreatic Tumor, Chinese…
- Key Laboratory of Research in Pancreatic Tumor, Chinese Academy of Medical Sciences, Beijing 100730, China; National Infrastructures for Translational Medicine, Peking Union Medical College Hospital, Beijing 100730, Chi…
Förderung
- Fundamental Research Funds for the Central Universities
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
- Peking Union Medical College
Zitieren
APA
Xu, W., Liu, J., Zhou, L., & Guo, J. (2026). Immune remodeling of liver metastases: From molecular mechanisms to therapeutic strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(4), 189618. https://doi.org/10.1016/j.bbcan.2026.189618
Vancouver
Xu W, Liu J, Zhou L, Guo J. Immune remodeling of liver metastases: From molecular mechanisms to therapeutic strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(4):189618. doi:10.1016/j.bbcan.2026.189618
BibTeX
@article{Xu2026,
author = {Xu, Wenchao and Liu, Jianzhou and Zhou, Li and Guo, Junchao},
title = {Immune remodeling of liver metastases: From molecular mechanisms to therapeutic strategies},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
volume = {1881},
number = {4},
pages = {189618},
doi = {10.1016/j.bbcan.2026.189618}
}
EUVIMED